Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Smith

Showing results (451-460 of 463) with videos related to

Pageof 47
Sort By:
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Archives of Internal Medicine|September 1, 1978
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicinC A Coltman, G P Bodey, J S Hewlett, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
JAMA|October 5, 1979
Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up reportA U Buzdar, G R Blumenschein, J U Gutterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancerA U Buzdar, S E Singletary, R L Theriault, et al.
Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
The Pharmacogenomics Journal|December 6, 2017
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primatesD I Staquicini, S D'Angelo, F Ferrara, et al.
Veterinary Pathology|July 4, 2007
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaS P Fosmire, R Thomas, C M Jubala, et al.
Pageof 47

Showing results (451-460 of 463) with videos related to

Sort By:
Pageof 47
Bone Marrow Transplantation|July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaA Shimoni, T L Smith, A Aleman, et al.
Archives of Internal Medicine|September 1, 1978
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicinC A Coltman, G P Bodey, J S Hewlett, et al.
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
JAMA|October 5, 1979
Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up reportA U Buzdar, G R Blumenschein, J U Gutterman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancerA U Buzdar, S E Singletary, R L Theriault, et al.
Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyH M Kuerer, L A Newman, T L Smith, et al.
The Pharmacogenomics Journal|December 6, 2017
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primatesD I Staquicini, S D'Angelo, F Ferrara, et al.
Veterinary Pathology|July 4, 2007
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaS P Fosmire, R Thomas, C M Jubala, et al.
Pageof 47